Get started
Author

Ziang Xu

ORCID: 0000-0002-3722-7036
Observed ORCID: 0000-0002-3722-7036
OpenAlex ID: A5065260548
The efficacy and safety of PI3K and AKT inhibitors for patients with cancer: A systematic review and network meta-analysis
2024 · Yingshi Zhang, Xiangbo Xu, et al. · European Journal of Pharmacology · 13
Dual-Stream Subspace Clustering Network for revealing gene targets in Alzheimer's disease
2022 · Minghan Chen, Shishen Jia, et al. · Computers in Biology and Medicine · 12
SCRN: Single-Cell Gene Regulatory Network Identification in Alzheimer's Disease
2024 · Wentao Zhu, Zhiqiang Du, et al. · IEEE Transactions on Computational Biology and Bioinformatics · 6
Association of calf circumference with osteoporosis and hip fracture in middle-aged and older adults: a secondary analysis
2024 · Mumin Cao, Yuanwei Zhang, et al. · BMC Musculoskeletal Disorders · 3
PDF
Role of basic chemistry education in clinical pharmacy requirements: evidence from cross-sectional study and narrative review
2026 · Yingshi Zhang, Ziang Xu, et al. · BMC Medical Education · 1
Uncovering the dynamic effects of DEX treatment on lung cancer by integrating bioinformatic inference and multiscale modeling of scRNA-seq and proteomics data
2022 · Minghan Chen, Chunrui Xu, et al. · Computers in Biology and Medicine · 1
Accelerated hematopoietic aging in type 1 diabetes links telomere attrition to myocardial infarction
2026 · Ziang Xu, Haibei Jiang, et al. · medRxiv
Shared genetic and neuroimmune architecture links type 1 diabetes with neurocognitive traits
2025 · Priscilla Saarah, Zehra A. Syeda, et al. · medRxiv
PDF
The Benefits and Drawbacks of PI3K and AKT Inhibitors for Patients with Cancer: A Systematic Review and Network Meta-Analysis
2024 · Yingshi Zhang, Xiangbo Xu, et al. · SSRN Electronic Journal
Works count: 9
Citation count: 35
H-index: 3
I10-index: 2
Year
Topic
Type